fbpx

Study Confirms Minimally-Invasive Pulmonx Therapy Effectively Treats Emphysema

  • Posted by Chris Kellett
  • On September 25, 2011
September 25, 2011, Amsterdam, Netherlands (ERS) – Pulmonx Inc. has just announced final results of its Chartis multi-centre study1, presented today at the European Respiratory Society’s 2011 Congress. This definitive data confirms that use of the Chartis® Pulmonary Assessment System to plan Zephyr® valve treatmentsis the key to successful EBV treatment of emphysema.
Read More

Study Shows Revolutionary New Treatment from Pulmonx is Consistently Effective in Treating Emphysema

  • Posted by Chris Kellett
  • On March 18, 2011
May 18, 2011, Denver, CO (ATS) – Pulmonx Inc. has announced new clinical data from its Chartis multicenter study1, presented at the American Thoracic Society’s 2011 International Conference. This definitive data clearly demonstrates that by using the Chartis® Pulmonary Assessment System to plan Zephyr® valve treatments physicians can consistently treat a broad spectrum of emphysema patients.
Read More